Intravenous administration of pantoprazole: An Austrian multicentre study

Clinical Drug Investigation

Volumn 22, Issue 8, 2002, Pages 507-511

  Wurzer, Herbert ^a   Hofbauer, Roland ^b   Worm, Harald C ^a   Frass, Michael ^c   Kaye, Kim ^d   Kaye, Alan D ^d  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; AUSTRIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DUODENUM ULCER; ENDOSCOPY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEPTIC ULCER; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REMISSION; STOMACH ULCER; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036049616     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222080-00002     Document Type: Article

References (19)

1. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion
2. Lack of pantoprazole drug interactions in man: An updated review
3. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection
4. Rapid improvement of symptomatology with pantoprazole, amoxycillin, and metronidazole in Helicobacter pylori-positive duodenal ulcer patients
5. Eradication of Helicobacter pylori with pantoprazole and two antibiotics: A comparison of two short-term regimens
6. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using intravenous-oral regimen
7. Wirksamkeit und sicherheit einer sequentiellen intravenösen und oralen behandlung mit pantoprazol bei refluxösophagitis
8. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study
9. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects
10. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
11. Pantoprazole therapy in the long-term management of severe acid peptic disease: Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies
12. Review article: Acid suppression in non-variceal acute upper gastrointestinal bleeding
13. Acid suppression in peptic ulcer haemorrhage: A meta-analysis
14. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole
15. Switching between intravenous and oral pantoprazole
16. Tolerability and efficacy of intravenous administration of pantoprazole in routine clinical practice
17. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper gastrointestinal tract: An open randomized controlled trial
18. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding
19. Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease